Cervical cerclage for prevention of preterm delivery: meta-analysis of randomized trials

OBJECTIVE: To estimate the effectiveness of prophylactic and therapeutic cerclage by meta-analysis of randomized clinical trials. DATA SOURCES: We searched the Cochrane Pregnancy and Childbirth Group specialized register of clinical trials (May 2002). Congress proceedings of international society meetings of fetal-maternal and reproductive medicine were searched by hand. METHODS OF STUDY SELECTION: Meta-analysis of randomized clinical trials comparing cervical cerclage with expectant management during pregnancy was performed. Further clarification was sought from trial authors when required. TABULATION, INTEGRATION, AND RESULTS: Six trials describing a total of 2175 women were analyzed. Prophylactic cerclage was compared with no cerclage in four trials. Pooled results failed to show a statistically significant reduction in pregnancy loss and preterm delivery rates, although a small reduction in births less than 33 weeks' gestation was seen in the largest trial (relative risk [RR] 0.75; 95% confidence interval [CI] 0.58 to 0.98). Cervical cerclage was associated with mild pyrexia, increased use of tocolytic therapy, and hospital admission but no serious morbidity. Two trials examined the role of therapeutic cerclage when ultrasound examination revealed a short cervix. Pooled results failed to show a reduction in total pregnancy loss, early pregnancy loss, or preterm delivery before 28 and 34 weeks in women assigned to cervical cerclage. CONCLUSION: The effectiveness of prophylactic cerclage in preventing preterm delivery in women at low or medium risk for second-trimester pregnancy loss has not been proven. The role of cerclage in women whose ultrasound reveals short cervix remains uncertain.     

Familial adenomatous polyposis with extracolonic manifestations--case report

The familial adenomatous polyposis syndrome is an autosomal dominant inherited disease characterized by progressive development of multiple adenomatous polyps throughout the colon and rectum. Due to the malignant potential of adenomatous polyps, colorectal cancer develops in 100% of cases, approximately 10-15 years after the onset of symptoms. Extracolonic manifestations of the disease including adenomatous polyps of the stomach, duodenum, small intestine and periampullatory region are rare. The etiology of the disease is germline mutation at the site of tumor suppressor gene located on chromosomes 5q21-22. A case is described of a 48-year-old man hospitalized at the Department of Abdominal Surgery, Sveti Duh General Hospital in Zagreb for the treatment of familial adenomatous polyposis syndrome. For some time the patient reported occasional abdominal pain, frequent stools and diarrhea with blood, anemia and body weight loss. Laboratory, radiology and endoscopy examinations verified multiple adenomatous polyps of the colon and rectum, also with polyps of the stomach, duodenum and jejunum. Histopathology confirmed the polyps to show moderately poorly differentiated cylindric epithelium and moderate to severe dysplasia. Radical surgery was required, so proctocolectomy with Brook ileostomy was performed. The postoperative recovery and wound healing were normal. The patient was discharged twelve days of the surgery for home care. Oncologic treatment was suggested. Verified extracolonic manifestations of the disease require periodical endoscopic follow up and possible treatment.     

The evidence base for fetal medicine

This chapter looks at the evidence base for the practice of fetal medicine and surgery. There is very little good-quality research and much activity is based on case reports and series. However, the philosophy of evidence-based practice is now accepted and new randomized trials are being published in the literature (e.g. fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia and laser treatment of the twin-to-twin transfusion syndrome). Many well established techniques would not be suitable for randomized trials but, as new techniques related to established practice are introduced (e.g. middle cerebral artery Doppler assessment), well-designed trials are essential to ensure they are safe, clinically useful and at least as good as standard practice. In this unique area of medicine, where ethical and emotional issues interplay with clinical practice, it is important not to introduce exciting techniques without solid evidence that they are beneficial both in the short and the long term.     

The role of alpha1- and alpha2-adrenoceptors in gender differences in cutaneous LD flux response to local cooling

The present study was designed to assess the hypothesis that alpha2-adrenergic response plays a predominant role in sex differences in cutaneous microvascular response to cold. For this purpose, we studied the effect of the selective alpha1-antagonist prazosin (1 microl of 1.2 mM solution) and the alpha2-antagonist yohimbine (1 microl of 12 mM solution) microinjected into the skin area where the laser-Doppler (LD) flux response to local cooling was measured in healthy male and female subjects. Multiple regression analysis showed correlation between LD flux response at the site of local cooling (direct response) and gender (P = 0.039). The LD flux decrease was smaller in males. The application of the yohimbine significantly diminished the LD flux response at the site of local cooling in females but not in males (P < 0.05). In contrast, the injection of prazosin did not significantly affect the response. These findings strongly support the suggestion of a decisive role of alpha2-adrenoceptors in cold-induced gender difference at the level of cutaneous microvasculature at the site of local cooling. Multiple regression analysis of LD flux response to cold exposure at the site distant to cooling (indirect response) also confirmed correlation between LD flux response and gender (P = 0.022). The LD flux decrease was smaller in males. The alpha1-antagonist abolished the LD flux response to cold exposure (P = 0.000). These results corroborate the importance of alpha1-adrenoceptors in skin microcirculatory response to indirect local cooling mediated by the sympathetic vascular reflex.     

Prevalence of primary headaches in children from Belgrade, Serbia.

The aim of our study is to estimate the prevalence of migraine and tension-type headaches in 7-12-year-old school children from Belgrade. The sample was drawn from a total of 1259 school children from randomly selected primary schools. The diagnosis was made on the basis of a clinical interview combined with the neurological examination. The prevalence of migraine increases with age from 0.5% at the age of seven, to 6.8% at the age of 12. Female to male ratio inverts with age: males predominate at age 7-9, but females predominate at age 10-12. The estimated prevalence of tension-type headache increases with age from 0.5% in 7-year olds to 2.4% in 12-year olds. Statistically, the onset of migraine occurs significantly earlier than that of tension-type headache. Migraine and tension-type headache are frequent headache types and have different demographic characteristics among children.     

Quality of life as defined by orthopedic oncology patients

Background: Quality of life (QOL), not just survival, is central to outcomes analysis in musculoskeletal oncology. However, little information exists about the patients' definition of what constitutes QOL. Methods: Self-administered outcomes questionnaires were given to 201 surgically treated patients with lower extremity tumors. Of these patients, 192 (137 with malignant tumors, 55 with benign tumors) provided a written definition of QOL. Their responses were independently collated and matched with clinical information. Results: For most patients (153, or 80%) the definition of QOL encompassed several attributes. A consistent combination of four major attributes was used in the QOL definition by 44 (32%) of the malignant cases and 19 (35%) of the benign cases. Differences in responses between men and women were idiosyncratic and more common in the benign group. Good family relations and good health were equally important to men and women. Responses varied by patient age. Older patients valued self-sufficiency and freedom from pain, whereas younger patients emphasized happiness, trust in God or church, achieving goals and being successful, and love. Those whose surgery was less extensive cited good family relations, the ability to function physically and emotionally, and having a good job or work. Conclusion: The variation in patients' perspectives and definitions of quality of life must be taken into account when assessing QOL in musculoskeletal oncology patients. Patients often emphasize concerns that are not adequately addressed by current outcomes measures in orthopedics and general oncology.